vs
Side-by-side financial comparison of NORTHERN TECHNOLOGIES INTERNATIONAL CORP (NTIC) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
NORTHERN TECHNOLOGIES INTERNATIONAL CORP is the larger business by last-quarter revenue ($23.3M vs $13.2M, roughly 1.8× TriSalus Life Sciences, Inc.). NORTHERN TECHNOLOGIES INTERNATIONAL CORP runs the higher net margin — 1.0% vs -73.9%, a 74.9% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 9.2%). NORTHERN TECHNOLOGIES INTERNATIONAL CORP produced more free cash flow last quarter ($-479.7K vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 5.8%).
Maxar Technologies Inc., was an American space technology company, specializing in geospatial intelligence, Earth observation, and on-orbit satellite servicing, satellite products, and related services. DigitalGlobe and MDA Holdings Company merged to become Maxar Technologies on October 5, 2017.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
NTIC vs TLSI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.3M | $13.2M |
| Net Profit | $237.8K | $-9.8M |
| Gross Margin | 36.0% | 86.7% |
| Operating Margin | 4.0% | -24.8% |
| Net Margin | 1.0% | -73.9% |
| Revenue YoY | 9.2% | 59.8% |
| Net Profit YoY | -57.6% | 3.5% |
| EPS (diluted) | $0.03 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.3M | $13.2M | ||
| Q3 25 | $22.3M | $11.6M | ||
| Q2 25 | $21.5M | $11.2M | ||
| Q1 25 | $19.1M | $9.2M | ||
| Q4 24 | $21.3M | $8.3M | ||
| Q3 24 | $23.3M | $7.3M | ||
| Q2 24 | $20.7M | $7.4M | ||
| Q1 24 | $20.8M | $6.5M |
| Q4 25 | $237.8K | $-9.8M | ||
| Q3 25 | $-1.1M | $-10.8M | ||
| Q2 25 | $121.8K | $-8.3M | ||
| Q1 25 | $434.3K | $-10.4M | ||
| Q4 24 | $561.1K | $-10.1M | ||
| Q3 24 | $1.8M | $-2.4M | ||
| Q2 24 | $976.6K | $-4.3M | ||
| Q1 24 | $1.7M | $-13.2M |
| Q4 25 | 36.0% | 86.7% | ||
| Q3 25 | 37.9% | 83.5% | ||
| Q2 25 | 38.4% | 83.9% | ||
| Q1 25 | 35.6% | 83.7% | ||
| Q4 24 | 38.3% | 85.3% | ||
| Q3 24 | 43.8% | 86.3% | ||
| Q2 24 | 38.2% | 87.6% | ||
| Q1 24 | 40.0% | 85.0% |
| Q4 25 | 4.0% | -24.8% | ||
| Q3 25 | 4.2% | -77.9% | ||
| Q2 25 | 4.0% | -65.4% | ||
| Q1 25 | -1.7% | -79.9% | ||
| Q4 24 | 5.2% | -91.8% | ||
| Q3 24 | 11.8% | -118.9% | ||
| Q2 24 | 7.4% | -111.0% | ||
| Q1 24 | 10.6% | -180.8% |
| Q4 25 | 1.0% | -73.9% | ||
| Q3 25 | -4.9% | -93.5% | ||
| Q2 25 | 0.6% | -73.9% | ||
| Q1 25 | 2.3% | -113.2% | ||
| Q4 24 | 2.6% | -122.4% | ||
| Q3 24 | 7.9% | -32.6% | ||
| Q2 24 | 4.7% | -58.8% | ||
| Q1 24 | 8.2% | -204.5% |
| Q4 25 | $0.03 | $-0.22 | ||
| Q3 25 | $-0.11 | $-0.96 | ||
| Q2 25 | $0.01 | $-0.27 | ||
| Q1 25 | $0.04 | $-0.39 | ||
| Q4 24 | $0.06 | $-0.38 | ||
| Q3 24 | $0.19 | $-0.12 | ||
| Q2 24 | $0.10 | $-0.21 | ||
| Q1 24 | $0.17 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.4M | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $72.4M | $-33.9M |
| Total Assets | $104.0M | $35.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.4M | $20.4M | ||
| Q3 25 | $7.3M | $22.7M | ||
| Q2 25 | $6.8M | $26.5M | ||
| Q1 25 | $5.1M | $13.0M | ||
| Q4 24 | $5.6M | $8.5M | ||
| Q3 24 | $5.0M | $11.3M | ||
| Q2 24 | $5.8M | $16.5M | ||
| Q1 24 | $4.8M | $4.0M |
| Q4 25 | $72.4M | $-33.9M | ||
| Q3 25 | $72.1M | $-26.7M | ||
| Q2 25 | $72.4M | $-19.4M | ||
| Q1 25 | $69.7M | $-34.4M | ||
| Q4 24 | $70.2M | $-25.9M | ||
| Q3 24 | $71.2M | $-20.4M | ||
| Q2 24 | $68.9M | $-25.3M | ||
| Q1 24 | $68.4M | $-36.0M |
| Q4 25 | $104.0M | $35.3M | ||
| Q3 25 | $102.7M | $36.5M | ||
| Q2 25 | $99.3M | $41.3M | ||
| Q1 25 | $93.7M | $28.6M | ||
| Q4 24 | $94.0M | $24.0M | ||
| Q3 24 | $94.7M | $27.5M | ||
| Q2 24 | $89.3M | $32.4M | ||
| Q1 24 | $87.3M | $17.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $341.9K | $-2.5M |
| Free Cash FlowOCF − Capex | $-479.7K | $-2.5M |
| FCF MarginFCF / Revenue | -2.1% | -19.1% |
| Capex IntensityCapex / Revenue | 3.5% | 0.3% |
| Cash ConversionOCF / Net Profit | 1.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.8M | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $341.9K | $-2.5M | ||
| Q3 25 | $-1.4M | $-3.7M | ||
| Q2 25 | $609.7K | $-7.3M | ||
| Q1 25 | $803.7K | $-4.5M | ||
| Q4 24 | $2.4M | $-5.7M | ||
| Q3 24 | — | $-10.8M | ||
| Q2 24 | $1.9M | $-13.4M | ||
| Q1 24 | — | $-10.9M |
| Q4 25 | $-479.7K | $-2.5M | ||
| Q3 25 | $-1.4M | $-3.9M | ||
| Q2 25 | $-171.2K | $-7.4M | ||
| Q1 25 | $293.1K | $-5.3M | ||
| Q4 24 | $1.2M | $-5.8M | ||
| Q3 24 | — | $-11.0M | ||
| Q2 24 | $869.4K | $-13.5M | ||
| Q1 24 | — | $-10.9M |
| Q4 25 | -2.1% | -19.1% | ||
| Q3 25 | -6.3% | -33.9% | ||
| Q2 25 | -0.8% | -66.1% | ||
| Q1 25 | 1.5% | -57.3% | ||
| Q4 24 | 5.5% | -69.7% | ||
| Q3 24 | — | -149.9% | ||
| Q2 24 | 4.2% | -183.1% | ||
| Q1 24 | — | -169.3% |
| Q4 25 | 3.5% | 0.3% | ||
| Q3 25 | 0.2% | 1.9% | ||
| Q2 25 | 3.6% | 0.8% | ||
| Q1 25 | 2.7% | 8.2% | ||
| Q4 24 | 5.7% | 0.6% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | 5.2% | 0.8% | ||
| Q1 24 | — | 1.0% |
| Q4 25 | 1.44× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 5.01× | — | ||
| Q1 25 | 1.85× | — | ||
| Q4 24 | 4.27× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.99× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NTIC
| Inside The USA To Unaffiliated Customers | $7.5M | 32% |
| Natur Tec | $6.0M | 26% |
| Acobal | $3.6M | 15% |
| Other | $2.7M | 12% |
| BR | $2.1M | 9% |
| Zerust OY | $1.4M | 6% |
TLSI
Segment breakdown not available.
